On Monday you’re going to hear a lot– an awful lot– about SPRINT. That’s the big NIH blood pressure trial which was stopped early. On September 11 an NIH press release trumpeted the positive results without revealing most of the important details. This Monday, finally, the results are scheduled to be presented at the American Heart…
You Don’t Know It But The Debate About SPRINT Is Already Over
Filed Under: People, Places & Events, Policy & Ethics Tagged With: blood pressure, embargo, guidelines, SPRINT
The PREVAIL Fail Revisited: Spinning The Truth
The biggest story at the American College of Cardiology meeting last week was the missing story. As reported here and just about everywhere else, the PREVAIL trial, probably the most-anticipated late-breaker of the meeting, was pulled from the program at the last minute by the ACC leadership after Boston Scientific broke the embargo by issuing…
Recent Comments